Portfolio by
Johnny Rice
2026 portfolio by
Johnny Rice
· Live scientific informatics demos.
2026 portfolio project by
Johnny Rice
. Live ChEMBL, UniProt, AACT SQL, and scientific informatics demos.
Informatics demo
ClariTrial
AI Clinical Trial Intelligence
Explore
Visualizations
Companies
Informatics
Résumé
Saved
Live data
Parsing your search query…
Explore
/
mRNA therapeutic cancer rare disease cardiovascular
Search
Status
Recruiting
Active
Not Yet
Completed
Terminated
Phase
Early Ph 1
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Clear filters
Pre-filtered to show active, later-stage trials with the strongest clinical signal.
7
results for
“mRNA therapeutic cancer rare disease cardiovascular”
· Phase 2
· Phase 1
↩
No exact matches for “mRNA therapeutic cancer rare disease cardiovascular”. Showing results for
“mRNA therapeutic cancer rare disease”
instead.
NCT00006136
Completed
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
Phase 2
Beta-Thalassemia
arginine butyrate
epoetin alfa
Boston University
15 participants
7 sites · United States, United Kingdom
More detail
CT.gov
Full analysis →
NCT04911621
Active
Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma
Phase 1
Phase 2
High Grade Glioma
Diffuse Intrinsic Pontine Glioma
Dendritic cell vaccination + temozolomide-based chemoradiation
Dendritic cell vaccination +- conventional next-line treatment
University Hospital, Antwerp
10 participants
1 site · Belgium
Completes Jun 2027
More detail
CT.gov
Full analysis →
NCT01456104
Completed
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma
Phase 1
Melanoma
Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
Memorial Sloan Kettering Cancer Center
9 participants
1 site · United States
Completes Jan 2023
More detail
CT.gov
Full analysis →
NCT04025567
Withdrawn
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral
Phase 2
Metastatic Hepatocellular Carcinoma
Hepatocellular Carcinoma
vancomycin
National Cancer Institute (NCI)
0
1 site · United States
Completes Dec 2021
More detail
CT.gov
Full analysis →
NCT00687596
Terminated
Results posted
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
Phase 2
Hepatocellular Carcinoma
TAC-101
Placebo
Taiho Oncology, Inc.
52 participants
1 site · Italy
Completes May 2010
More detail
CT.gov
Full analysis →
NCT05223036
Suspended
Testing Obeticholic Acid for Familial Adenomatous Polyposis
Phase 2
Attenuated Familial Adenomatous Polyposis
Colorectal Carcinoma
Duodenal Carcinoma
Biopsy Procedure
Biospecimen Collection
Gastrointestinal Endoscopy
+3 more
National Cancer Institute (NCI)
80 participants
7 sites · United States, Puerto Rico
Completes Jan 2029
More detail
CT.gov
Full analysis →
NCT07307053
Not Yet Recruiting
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
Phase 1
Phase 2
Rare Malignant Neoplasm
Advanced Solid Tumors
Metastatic Solid Tumors
BL-B01D1
VSV injection
CVL006
+17 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
600 participants
Completes Jan 2029
More detail
CT.gov
Full analysis →
Previous
1–7 of 7
Next